Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionNasal spray combination of bepotastine besylate, a selective histamine H1 receptor (HRH1) antagonist, and a steroid
Molecular Target Histamine H1 receptor (HRH1)
Mechanism of ActionHistamine H1 receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationRhinitis
Indication DetailsTreat seasonal allergic rhinitis (SAR)
Regulatory Designation
PartnerMitsubishi Tanabe Pharma Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today